Lipocine Inc.
LPCN· Nasdaq
Released Nov 8, 2023, during market hours
10-Q filed Nov 8, 2023, 39 days after period end · 0001493152-23-039861
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | -$3.12M | — | $54.99K | $0.00 |
| Net Income | -$6.65M | -$2.41M | -$3.08M | -$4.31M |
| EPS Diluted | -$1.27 |
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR
| -$0.52 |
| -$0.04 |
| -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.